Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FQAFC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,750
Award facts
- Contract value 100% obligated
- $48,749.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,749.85 by the Defense Logistics Agency (DLA) on May 29, 2025, for the supply of Stelara 90 mg/ml syringes. This delivery order, which carries no set-aside designation, is scheduled for completion by June 20, 2025, with performance to be executed at the vendor's Park Ridge, Illinois location. The award represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle that enables the agency to issue delivery orders for comprehensive pharmaceutical supplies supporting Department of Defense healthcare facilities nationwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for pharmaceutical distribution contracts with military and federal healthcare systems. The company's portfolio demonstrates consistent success in securing delivery orders for a diverse range of pharmaceutical products, including specialty medications, biologics, and medical consumables. Stelara, an immunosuppressant biologic commonly used in the treatment of autoimmune conditions, aligns with the company's established expertise in distributing branded pharmaceutical products to defense health system facilities across the United States.
Quick answers
Who was awarded contract SPE2DB25FQAFC?
SPE2DB25FQAFC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 29, 2025.
How much is contract SPE2DB25FQAFC worth?
The government has obligated $48,750 on SPE2DB25FQAFC.
Is contract SPE2DB25FQAFC an order under another contract?
Yes. SPE2DB25FQAFC is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAFC competed?
The extent of competition for SPE2DB25FQAFC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award